News / Global Alerts - 4 months ago
New cell-based gene therapies provide hope for sickle cell disease patients
By Stacy M. BrownNNPA Newswire Senior National Correspondent@StacyBrownMedia The U.S. Food and Drug Administration (FDA) has greenlit two revolutionary cell-based gene therapies, Casgevy and Lyfgenia, marking a significant leap forward in treatin...